Navigate Fool.com
Will PETX beat
the market?



15.30 1.33 (9.52%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.07
Previous Close $13.97
Daily Range $14.04 - $15.61
52-Week Range $6.56 - $29.32
Market Cap $451.0M
P/E Ratio -35.82
Dividend (Yield) $0.00 (0.0%)
Volume 282,332
Average Daily Volume 306,986
Current FY EPS -$1.48

How do you think PETX
will perform against the market?

Top PETX Bull/Bear Pitches


There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!


There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics

Last week's three worst performing biotech stocks.

Here Are Some Ways To Get In On A Booming Market For Pet Stocks

3 Big Movers in Cancer Care -- Ariad Pharmaceuticals, Galena Biopharma, and Aratana Therapeutics

Ariad Pharmaceuticals (NASDAQ: ARIA), Galena Biopharma (NASDAQ: GALE), and Aratana Therapeutics (NASDAQ: PETX) have all served up a roller-coaster ride for shareholders in 2014.

Despite Dilution, Aratana Therapeutics Can Keep Climbing

Aratana Therapeutics recently announced conditional approval by the USDA of its lymphoma treatment for dogs, a big potential revenue driver.

3 Stocks You Must Follow This Morning: Cell Therapeutics Inc., Aratana Therapeutics Inc., and Therap

Cell Therapeutics, Aratana Therapeutics, and TherapeuticsMD could be three health care stocks worth watching today. Here’s why.

This Week in Biotech

An FDA approval, a mixed batch of clinical data, a welcome pipeline update, and an ongoing patent battle are this week's must-watch biotech stories.

A Year-End Look at 3 High-Flying Biotech IPOs of 2013: PETX, RCPT, STML

Aratana Therapeutics Inc., Receptos Inc., and Stemline Therapeutics Inc. are three biotech IPOs of 2013 that are finishing the year with strong gains. Can they continue soaring into 2014?

Why Aratana Therapeutics Inc. Shares Jumped

Aratana provides a pipeline update and shares ascend to the heavens. Should investors be howling with excitement or barking with displeasure?

3 Horrendous Health-Care Stocks This Week

Which health-care stocks might make Santa's naughty list for the past week? Enanta, Rockwell Medical, and Aratana rank at the top of that list.

After The IPO Pop: Sad Stories Often Untold

See More PETX News...




ARATANA THERAPEUTICS INC COM USD0.001 Website: http://www.aratana.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks